SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062822-22-000024
Filing Date
2022-05-25
Accepted
2022-05-25 08:27:39
Documents
13
Period of Report
2022-05-20
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20220520.htm   iXBRL 8-K 47880
2 EX-3.1 exh31-fifthamendedandresta.htm EX-3.1 94230
  Complete submission text file 0001062822-22-000024.txt   300996

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20220520.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20220520_lab.xml EX-101.LAB 24977
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20220520_pre.xml EX-101.PRE 13189
7 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20220520_htm.xml XML 11083
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 22958927
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences